4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000029
President and CEO sold 15,200 shares at $3.47 ($52,753)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph President and CEO | 2024-01-19 | Sale 10b5-1 | −15,200 | $3.47 | $52,753 | 502,485 | D |
| Open-market sales · 15,200 sh · avg $3.47 · $52,753 | |||||||
Loading xslF345X05/wk-form4_1705709243.xml…